James D. Bowen

28.9k citations

193 papers · 11.1k indexed · 2 hit papers · h-index 60

Impact in

Psychiatry and Mental health top 0.2%
- Dementia and Cognitive Impairment Research
Geriatrics and Gerontology top 0.5%
- Frailty in Older Adults

Papers in

Psychiatry and Mental health 61
- Dementia and Cognitive Impairment Research 54
Pathology and Forensic Medicine 66
- Multiple Sclerosis Research Studies 62

Co-authors: Wayne C. McCormick Eric B. Larson Walter A. Kukull Linda Teri Paul K. Crane Gerald van Belle Susan M. McCurry Laura E. Gibbons
Journals: Neurology (19 papers)Journal of the American Geriatrics Society (14 papers)Multiple Sclerosis Journal (13 papers)Alzheimer s & Dementia (6 papers)Biology of Blood and Marrow Transplantation (6 papers)
Partner nations: United States Canada Netherlands

In The Last Decade

James D. Bowen

183 papers receiving 10.6k citations

Hit Papers

align trajectories log scale

Exercise Is Associated with Reduced Risk for Incident Dementia among Persons 65 Years of Age and Older 2006 · 1.1k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Annals of Internal Medicine
2002 Archives of Neurology

Peers

Countries citing papers authored by James D. Bowen

Since Specialization

Citations

This map shows the geographic impact of James D. Bowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Bowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Bowen more than expected).

Fields of papers citing papers by James D. Bowen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James D. Bowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Bowen. The network helps show where James D. Bowen may publish in the future.

Co-authors

The 25 scholars most cited alongside James D. Bowen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James D. Bowen Line = papers co-authored together James D. Bowen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Role of Spatial Water Right Data in Understanding Anthropogenic Effects on the Water Balance JAWRA Journal of the American Water Resources Association ·James D. Bowen, Ginger B. Paige, Emilie Morinière, F. Nippgen	2025	0
2	Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study Multiple Sclerosis Journal ·Victoria M. Leavitt, Robert J. Fox, Jop Mostert, Miguel D’haeseleer, Afni Nurafni, Luís Brieva, Pavle Repovic, James D. Bowen, Jacynthe Comtois, Bernard M.J. Uitdehaag, Eva Strijbis, Gary Cutter, Marcus Koch	2025	1
3	Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study Annals of Clinical and Translational Neurology ·Scott D. Newsome, Lawrence Goldstick, Derrick Robertson, James D. Bowen, Robert T. Naismith, A. A. Eze, W. Clark Gilpiin, Heidemarie Kletzl, Andris Potrebko, Oscar Bortolami, Johanna Loewenstein, Alan Bacon, M. Mayo, Yun‐An Shen, Alejandro Stella, Robert A Bermel	2024	2
4	Diroximel Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: NEDA-3 After Re-Baselining in the Phase 3 EVOLVE-MS-1 Study Advances in Therapy ·James D. Bowen, Eljihad Akbari Syukriah, Samuel F. Hunter, Tsuboya Ryusuke, Umair Shah, Matthew Scaramozza, Takahiro Yamanishi, Florian Then Bergh	2024	0
5	Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis Neurology ·Eva Strijbis, Jop Mostert, Jacynthe Comtois, Amber Salter, Pavle Repovic, James D. Bowen, Bernard M.J. Uitdehaag, Gary Cutter, Marcus Koch	2024	2
6	Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset Multiple Sclerosis Journal ·Marcus Koch, Afni Nurafni, Luís Brieva, Jop Mostert, Eva Strijbis, Jacynthe Comtois, Pavle Repovic, James D. Bowen, Jerry S. Wolinsky, Fred Lublin, Gary Cutter	2023	6
7	Remission of severe myasthenia gravis after autologous stem cell transplantation Annals of Clinical and Translational Neurology ·Leena Sivula, 李应波, Kevin C. O’Connor, Richard J. Nowak, Minh Pham, Abeer Obaid, Jungtaek Lee, Anang Fatma T Jawali, Peter A. McSweeney, Michael Pearlman, Michael Tees, James D. Bowen, Richard A. Nash, George E. Georges	2023	1
8	The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials Multiple Sclerosis Journal ·Eva Strijbis, Pavle Repovic, Jop Mostert, James D. Bowen, Bernard M.J. Uitdehaag, Gary Cutter, Marcus Koch	2022	6
9	Diabetic Retinopathy and Dementia Association, Beyond Diabetes Severity American Journal of Ophthalmology ·Cecilia S. Lee, Lu DAI, Yu‐Ru Su, Rod Walker, Marian Blazes, Susan M. McCurry, James D. Bowen, Wayne C. McCormick, Aaron Lee, Edward J. Boyko, Ann M. O’Hare, Eric B. Larson, Paul K. Crane	2022	11
10	A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclerosis immediately following a relapse Multiple Sclerosis Journal - Experimental Translational and Clinical ·Benjamin Greenberg, James D. Bowen, Enrique Álvarez, Moses Rodriguez, Anthony O. Caggiano, Arthur E. Warrington, Ping Zhao, Andrew Eisen	2022	7
11	MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis Multiple Sclerosis Journal ·Marcus Koch, Jop Mostert, Pavle Repovic, James D. Bowen, Eva Strijbis, Bernard M.J. Uitdehaag, Gary Cutter	2021	11
12	Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS Multiple Sclerosis Journal ·Marcus Koch, Jop Mostert, Pavle Repovic, James D. Bowen, Eva Strijbis, Bernard M.J. Uitdehaag, Gary Cutter	2021	3
13	Subgroup analysis of clinical and MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study Multiple Sclerosis and Related Disorders ·Bruce Cree, James D. Bowen, Hans‐Peter Hartung, Patrick Vermersch, Edgar Teodoro da Cunha, Doris Damian, Yann Hyvert, Fernando Dangond, Andrew Galazka, Megan Grosso, Daniel L. Jones, Thomas Leist	2020	8
14	Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation Biology of Blood and Marrow Transplantation ·Jeffrey A. Cohen, Laura Baldassari, Harold Atkins, James D. Bowen, Christopher Bredeson, Paul A. Carpenter, John R. Corboy, Mark S. Freedman, Linda M. Griffith, Robert Lowsky, Navneet S. Majhail, Paolo A. Muraro, Richard A. Nash, Marcelo C. Pasquini, Stefanie Sarantopoulos, Bipin N. Savani, Jan Storek, Keith M. Sullivan, George E. Georges	2019	72
15	Iron-Insensitive Quantitative Assessment of Subcortical Gray Matter Demyelination in Multiple Sclerosis Using the Macromolecular Proton Fraction American Journal of Neuroradiology ·Vasily L. Yarnykh, Isaac Zaskpaya Naab, G. Aitmagambetova, Pavle Repovic, 高亚强, Peiqing Qian, Brian Cary, Beena Gangadharan, James D. Bowen	2018	28
16	A real-world comparison of relapse rates, healthcare costs and resource use among patients with multiple sclerosis newly initiating subcutaneous interferon beta-1a versus oral disease-modifying drugs Multiple Sclerosis Journal - Experimental Translational and Clinical ·James D. Bowen, Chris M Kozma, Megan Grosso, Amy Phillips	2018	8
17	Blood Pressure and Brain Injury in Older Adults: Findings from a Community‐Based Autopsy Study Journal of the American Geriatrics Society ·Céline Bailly, Eric B. Larson, Joshua A. Sonnen, Jane B. Shofer, Wayne C. McCormick, James D. Bowen, Thomas J. Montine, Ge Li	2009	52
18	Calibration Performance of a Two-Dimensional, Laterally-Averaged Eutrophication Model of a Partially Mixed Estuary Estuarine and Coastal Modeling ·James D. Bowen	2000	6
19	Evaluating the Uncertainty in Water Quality Predictions—A Case Study Estuarine and Coastal Modeling ·James D. Bowen	1998	3
20	Simple device for the spectrophotometric assay of immobilized enzymes Biotechnology and Bioengineering ·Tang Yu, James D. Bowen	1980	5

About James D. Bowen

James D. Bowen is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine, Geriatrics and Gerontology, Neuropsychology and Physiological Psychology and Neurology, having authored 193 papers that have together received 11.1k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (62 papers), Dementia and Cognitive Impairment Research (54 papers), Alzheimer's disease research and treatments (27 papers), Polyomavirus and related diseases (16 papers), Peripheral Neuropathies and Disorders (10 papers), Health Systems, Economic Evaluations, Quality of Life (10 papers), Frailty in Older Adults (10 papers) and Autoimmune and Inflammatory Disorders Research (7 papers). The work is most often cited by research in Psychiatry and Mental health (3.9k citations), Geriatrics and Gerontology (704 citations), Pathology and Forensic Medicine (1.9k citations), Physiology (2.8k citations) and Neurology (858 citations). James D. Bowen has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Wayne C. McCormick, Eric B. Larson, Walter A. Kukull, Linda Teri, Paul K. Crane, Gerald van Belle, Susan M. McCurry, Laura E. Gibbons, Eric B. Larson and George H. Kraft. Their work appears in journals such as Neurology, Journal of the American Geriatrics Society, Multiple Sclerosis Journal, Alzheimer s & Dementia and Biology of Blood and Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact